NEW YORK, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Dentsply Sirona Inc. (NASDAQ: XRAY) and certain of the company’s senior executives for potential violations of the federal securities laws. If you invested in Dentsply, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/dentsply-sirona-inc. Investors have until January 27, 2025, to ask the Court to be appoi ...

RADNOR, Pa., Nov. 17, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of DENTSPLY SIRONA Inc. (NASDAQ: XRAY) (“DENTSPLY”). On October 24, 2024, DENTSPLY issued a press release "announc[ing] the voluntary suspension of sales and marketing of its Byte Aligners and Impression Kits while the Company conducts a review of certain regulatory requirements related to these ...

RADNOR, Pa., Nov. 16, 2024 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of DENTSPLY SIRONA Inc. (NASDAQ: XRAY) ("DENTSPLY").On October 24, 2024, DENTSPLY issued a press release "announc[ing] the voluntary suspension of sales and marketing of its Byte Aligners and Impression Kits while the Company conducts a review of certain regulatory requirements related to these produ ...

Have you assessed how the international operations of Dentsply International (XRAY) performed in the quarter ended September 2024? For this dental products manufacturer, possessing an expansive global footprint, parsing the trends of international revenues could be critical to gauge its financial resilience and growth prospects.In today's increasingly interconnected global economy, a company's ability to tap into international markets can be a pivotal factor in shaping its overall financial health and growt ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-16211 DENTSPLY SIRONA Inc. (Exact name of registrant as specified in its charter) Delaware 39-1434669 (State or other jurisdiction of (I.R.S ...

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Q3 2024 Earnings Conference Call November 7, 2024 8:30 AM ET Company Participants Andrea Daley - Vice President of Investor Relations Simon Campion - President and Chief Executive Officer Glenn Coleman - Executive Vice President and Chief Financial Officer Rich Rosenzweig - Executive Vice President, Corporate Development, General Counsel and Secretary Conference Call Participants David Saxon - Needham & Company Kevin Caliendo - UBS Jeffrey Johnson - Baird Jason Bednar - Pi ...

Third Quarter 2024 Earnings Conference Call November 7, 2024 Forward-Looking Statements and Associated Risks All statements in this presentation that do not directly and exclusively relate to historical facts constitute "forward-looking statements." Such statements are subject to numerous assumptions, risks, uncertainties and other factors that could cause actual results to differ materially from those described in such statements, many of which are outside of our control, including those described in Part ...

DENTSPLY SIRONA Inc. (XRAY) reported third-quarter 2024 adjusted earnings per share (EPS) of 50 cents, which beat the Zacks Consensus Estimate of 48 cents by 4.2%. The bottom line increased 2% on a year-over-year basis.On a GAAP basis, the company reported a loss of $2.46 per share compared with $1.25 per share in the year-ago quarter.Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar.Revenue DetailsRevenues in the reported quarter totaled $951 million, surpassing the Zacks Consensus E ...

Dentsply Sirona Inc. XRAY shares are trading lower on Thursday.The company reported third-quarter adjusted earnings per share of 50 cents, beating the street view of 47 cents. Quarterly sales of $951 million (increased 0.5%) outpaced the analyst consensus estimate of $939.10 million.The company recorded a $495 million non-cash goodwill impairment charge in the Orthodontic and Implant Solutions segment. This was due to ongoing economic challenges, legislative changes affecting Byte, weaker demand, increased ...

Dentsply International (XRAY) reported $951 million in revenue for the quarter ended September 2024, representing a year-over-year increase of 0.4%. EPS of $0.50 for the same period compares to $0.49 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $942.6 million, representing a surprise of +0.89%. The company delivered an EPS surprise of +4.17%, with the consensus EPS estimate being $0.48.While investors scrutinize revenue and earnings changes year-over-year and how they compare ...